Division of Eli Lilly & Co.
Latest From Hypnion Inc.
Scrip spoke with Managing Director Julie Sunderland about Biomatics' new $300m fund. Also, Silicon Valley Bank reveals its surprising Leerink buy, Perceptive Advisors raises $675m, Roivant brings in another $200m, and cell and gene therapy financings surge in the third quarter.
- Therapeutic Areas
- Neurology, Nervous System > Sleep Disorders
- North America
- Parent & Subsidiaries
- Eli Lilly & Co.
- Senior Management
Michael Fitzgerald, VP, Fin. & CFO
Robert M Poole, MD, CMO
Anita P Hoffer, PhD, VP, Bus. Dev.
- Contact Info
Phone: (781) 778-0300
500 Patriot Way
Lexington, MA 02421
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.